Antonio Passaro is a medical oncologist within the Division of Thoracic Oncology at the European Institute of Oncology in Milan, Italy. Holding a PhD in molecular medicine with a focus on lung cancer. Dr Passaro’s numerous areas of research in NSCLC encompass topics including predictive biomarkers, targeted and immune cancer therapeutics. Authors of more than 100 publications focused on NSCLC, and he is Principal or Sub-Investigator in many sponsored and academic trials, spanning a range of novel therapies. Dr Passaro is a member of the ESMO Council, Chair of the Communication Committee, and a member of the ESMO Lung Cancer Faculty.